LEI 984500Q1EA0CE15BC797

CasInvent Pharma, a.s.

Awards tracked

2

Value

€485,034

Countries

CZ

Download sample CSV

Contract awards & public grants

Revolutionizing AML Therapy - A First-in-Class CK1 Inhibitor for Relapsed Refractory Patients → CASINVENT PHARMA A.S.

European Commission · CZ · Grant · 2026-07-14

€485,034

CEItec Postdoctoral EXperts → CASINVENT PHARMA A.S.

European Commission · CZ · Grant · 2025-05-26

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.